Get complete access to comprehensive company data for Impilo Pharmaceuticals Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Impilo Pharmaceuticals Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 20.00 lakh
₹ 3.00 lakh
05 Jan 2015
31 Mar 2019
Impilo Pharmaceuticals Private Limited is an Indian private limited company incorporated on 05 Jan 2015. The company's registered office is situated in Bangaluru, Karnataka, India.
The current status of Impilo Pharmaceuticals Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2019 (FY 2018-2019).
Impilo Pharmaceuticals Private Limited is a company limited by shares with an authorized capital of ₹20.00 lakh and a paid-up capital of ₹3.00 lakh as per the records maintained by the Ministry of Corporate Affairs (MCA).
Impilo Pharmaceuticals Private Limited has 6 directors. The directors of the company include Sandhya Ashish Shinge, Ravishankar Krishnamurthy, Kannambadi Thammaiah Subramaniam, Vijay Mathodu Eshwarappa.
The registered office of Impilo Pharmaceuticals Private Limited is located at Shed No. 101, 1St Floor, Ind Esta, Rajajinagar Bangalore Karnataka 560010 India in Bangaluru, Karnataka, India.
- CIN/LLPIN/FCRN: U24232KA2015PTC078093
- Legal Name: Impilo Pharmaceuticals Private Limited
- ROC Code: Roc Bangalore
- Company No.: 078093
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: Pharmaceuticals
- Date of AGM: 30 Sep 2019
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Impilo Pharmaceuticals Private Limited |
|---|
Frequently Asked Questions
- aruna mallippanahalli dharmeshappa
- kannambadi thammaiah subramaniam
- pradeep tokasandra siddegowda
- ravishankar krishnamurthy
- sandhya ashish shinge
- vijay mathodu eshwarappa